Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Effectiveness of Injectable Alendronat for Bone Defect due to Osteoporosis

View through CrossRef
Alendronate is a drug of the bisphosphonate group used for the treatment and prevention of osteoporosis in postmenopausal women. However, when given orally, alendronate can cause indigestion and osteonecrosis of the jaw. It also has a poor bioavailability. Taking these disadvantages into account, an injection formulation of alendronate was created in this study to act on the site locally. Beside alendronate, the injection also contains bovine hydroxyapatite and gelatin as alendronate carriers. Both, besides being able to act as carriers, are also able to reduce bone damage caused by osteoporosis. The aim of this study was to determine the effectiveness of alendronate injection for fractures caused by osteoporosis in mouse models that were ovariectomized. The parameters used in this study were ALP concentration in blood and bone radiology. The results of ALP concentration showed that there were no significant differences in each group. The average ALP concentration of the negative control group was 277.67 ± 46.090, in the positive control group 270.33 ± 189.716, in the BHA-Gel group 406.33 ± 212.547 and in the BHA-Gel Alendronate group 325.00 ± 73.750. Bone radiology results and macroscopic observations still showed bone defects in each group.Yet in the negative control group, the BHAGel-Alendronate group and the BHA-Gel group, bone defects were almost entirely ameliorated. On the contrary, bone defects were still present in the positive control group. Based on the results obtained, it was shown that the injection of alendronate has not been shown to significantly overcome osteoporosis fractures. Keywords: Osteoporosis, Alendronate, Ovariectomy, Bovine hydroxyapatite, Gelatin
Title: Effectiveness of Injectable Alendronat for Bone Defect due to Osteoporosis
Description:
Alendronate is a drug of the bisphosphonate group used for the treatment and prevention of osteoporosis in postmenopausal women.
However, when given orally, alendronate can cause indigestion and osteonecrosis of the jaw.
It also has a poor bioavailability.
Taking these disadvantages into account, an injection formulation of alendronate was created in this study to act on the site locally.
Beside alendronate, the injection also contains bovine hydroxyapatite and gelatin as alendronate carriers.
Both, besides being able to act as carriers, are also able to reduce bone damage caused by osteoporosis.
The aim of this study was to determine the effectiveness of alendronate injection for fractures caused by osteoporosis in mouse models that were ovariectomized.
The parameters used in this study were ALP concentration in blood and bone radiology.
The results of ALP concentration showed that there were no significant differences in each group.
The average ALP concentration of the negative control group was 277.
67 ± 46.
090, in the positive control group 270.
33 ± 189.
716, in the BHA-Gel group 406.
33 ± 212.
547 and in the BHA-Gel Alendronate group 325.
00 ± 73.
750.
Bone radiology results and macroscopic observations still showed bone defects in each group.
Yet in the negative control group, the BHAGel-Alendronate group and the BHA-Gel group, bone defects were almost entirely ameliorated.
On the contrary, bone defects were still present in the positive control group.
Based on the results obtained, it was shown that the injection of alendronate has not been shown to significantly overcome osteoporosis fractures.
Keywords: Osteoporosis, Alendronate, Ovariectomy, Bovine hydroxyapatite, Gelatin.

Related Results

Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Objective: To determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population...
Poster 107: The Use of Coacervate Sustained Release System to Identify the Most Potent BMP for Bone Regeneration
Poster 107: The Use of Coacervate Sustained Release System to Identify the Most Potent BMP for Bone Regeneration
Objectives: Bone morphogenetic proteins (BMPs) belong to the transforming growth factor superfamily that were first discovered by Marshall Urist. There are 14 B...
Underweight Sebagai Faktor Resiko Osteoporosis Pada Lansia
Underweight Sebagai Faktor Resiko Osteoporosis Pada Lansia
Osteoporosis is a bone disease characterized by decreased bone density. The incidence of osteoporosis increases with age, especially age ≥ 50 years. Research from the International...
P05 Osteoporosis in thalassemia; a case with multifactorial aetiology
P05 Osteoporosis in thalassemia; a case with multifactorial aetiology
Abstract Introduction Thalassemia patients are prone to osteoporosis due to multifactorial reasons, including anaemia, bone marr...
Manfaat Ekstrak Dandelion Dalam Mencegah Osteoporosis
Manfaat Ekstrak Dandelion Dalam Mencegah Osteoporosis
Osteoporosis adalah penyakit tulang sistemik yang ditandai oleh penurunan densitas massa tulang sehingga tulang menjadi rapuh dan mudah patah. Karakteristik osteoporosis adalah dit...
pdf Nestatin-1 Level as Potential Parameters in T2DM with and Without Osteoporosis
pdf Nestatin-1 Level as Potential Parameters in T2DM with and Without Osteoporosis
In osteoporosis (OP) disease, the strength of bones is decreased, and it is mostly correlated with the loss of bone tissues and destruction of bone micro structure, making the pati...
The role of CD8+ T cells in the immunoregulation of osteoporosis
The role of CD8+ T cells in the immunoregulation of osteoporosis
Introduction Osteoporosis weakens the skeleton by lowering bone mass and damaging bone microarchitecture. A growing body of evidence poin...
Evaluation of Osteoporosis Frequency in Patients With Recurrent Kidney Stones
Evaluation of Osteoporosis Frequency in Patients With Recurrent Kidney Stones
Osteoporosis is defined as a reduction in bone density up to 2.5 standard deviations less than the maximum mean bone density in humans. It is estimated that 50% to 80% of the diffe...

Back to Top